Published in J Am Coll Surg on August 01, 1999
The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol (2007) 2.60
Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg (2005) 1.17
Axillary staging of breast cancer and the sentinel node. J Clin Pathol (2000) 1.08
History of sentinel node and validation of the technique. Breast Cancer Res (2001) 1.05
Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging (2010) 1.02
Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg (2002) 0.91
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach. Nucl Med Biol (2015) 0.76
Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med (1999) 4.78
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med (1997) 3.65
Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg (1995) 3.62
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature (1989) 3.31
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13
Transmission thresholds for dengue in terms of Aedes aegypti pupae per person with discussion of their utility in source reduction efforts. Am J Trop Med Hyg (2000) 2.95
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg (1997) 2.49
Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28
Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol (1999) 2.23
Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol (1985) 2.10
Summary of findings of the School Health Education Evaluation: health promotion effectiveness, implementation, and costs. J Sch Health (1985) 1.96
The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR Am J Roentgenol (1991) 1.91
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90
Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol (1999) 1.82
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg (1999) 1.77
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Effects of dissolved organic carbon and salinity on bioavailability of mercury. Appl Environ Microbiol (1997) 1.64
Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol (2001) 1.61
Necrotizing lymphadenitis. A study of 30 cases. Am J Surg Pathol (1983) 1.60
Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol (1987) 1.59
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol (1985) 1.54
Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem (1996) 1.54
Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer (1991) 1.53
Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J (2001) 1.53
The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol (2006) 1.51
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. J Infect (1991) 1.47
Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer? Ann Surg Oncol (2000) 1.41
[Ductal carcinoma in situ of the breast]. Schweiz Med Wochenschr (1995) 1.38
Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem (1999) 1.37
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem (1997) 1.35
Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer (2000) 1.34
Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol (2001) 1.33
Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol (2001) 1.32
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am (1999) 1.30
The mammography audit: a primer for the mammography quality standards act (MQSA). AJR Am J Roentgenol (1995) 1.29
Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol (1986) 1.28
Isolation and characterization of a clone encoding a major allergen (Bla g Bd90K) involved in IgE-mediated cockroach hypersensitivity. J Allergy Clin Immunol (1996) 1.28
Clinical aspects of unknown primary melanoma. Ann Surg (1980) 1.27
CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood (2001) 1.27
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res (2001) 1.24
A yeast cyclophilin gene essential for lactate metabolism at high temperature. Proc Natl Acad Sci U S A (1992) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22
Generation of dynorphin knockout mice. Brain Res Mol Brain Res (2001) 1.22
Histiocytic malignancies. Morphologic, immunologic, and enzymatic heterogeneity. Am J Surg Pathol (1984) 1.21
Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer (2001) 1.19
Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis (2000) 1.19
Construction and screening of a genomic library specific for mouse chromosome 16. Proc Natl Acad Sci U S A (1989) 1.16
Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin (2000) 1.16
Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.15
Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers (1992) 1.14
Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol (2001) 1.13
Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg (1998) 1.12
Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res (1998) 1.12
Mechanisms of increasing expression of a yeast gene in Escherichia coli. J Mol Biol (1980) 1.12
Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res (2001) 1.11
Entomological studies at an enzootic Venezuelan equine encephalitis virus focus in Guatemala, 1977-1980. Am J Trop Med Hyg (1986) 1.11
Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med (1982) 1.09
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res (2001) 1.09
FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene (2012) 1.08
Margin status and local recurrence after breast-conserving surgery. Arch Surg (1994) 1.08
Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol (1985) 1.07
Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol (1999) 1.07
Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities. Hum Pathol (1984) 1.06
Changes in concentrations of selenium and mercury in largemouth bass following elimination of fly ash discharge to a quarry. Chemosphere (1994) 1.05
Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res (2000) 1.04
Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. J Natl Cancer Inst (1979) 1.02
Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol (1996) 1.01
Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid (1999) 1.01
Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem (2000) 1.01
Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection. Clin Immunol Immunopathol (1988) 1.01
Accuracy of screening mammography using single versus independent double interpretation. AJR Am J Roentgenol (2000) 1.01
Cell-density-dependent sensitivity of a mer-lux bioassay. Appl Environ Microbiol (1997) 1.01
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer (1998) 1.00
Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care (1998) 1.00
Impairment in motor learning of somatostatin null mutant mice. Brain Res (2001) 0.97
Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg (2001) 0.97
The treatment of malignant histiocytosis. Blood (1984) 0.97
The operative management of coexisting thyroid and parathyroid disease. Arch Surg (1990) 0.96
LDH and melanoma. Cancer (1983) 0.96
Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A (2001) 0.96
See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol (1999) 0.96
Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Arch Surg (1988) 0.96
Form of mercury in stream fish exposed to high concentrations of dissolved inorganic mercury. Chemosphere (1995) 0.95
Lymphocyte immunophenotyping of B-cell lymphomas: a flow cytometric analysis of neoplastic and nonneoplastic cells in 271 cases. Clin Immunol Immunopathol (1988) 0.95
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer (1995) 0.95